PubMed Health⌕ Search

Biomedical subjects

F Powrie

Publications and source records attributed to F Powrie.

44 records · Page 3Linked to original sources
PubMed1990

Memory CD4+ T cells in man form two distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen, CD45.

The leucocyte common antigen, CD45 (T200, Ly-5), exists in a number of isoforms generated by differential usage of three exons that code for an extracellular region close to the NH2 terminus. Use of antibodies to different isoforms of CD45 has lead to the identification of two subsets of CD4+ T cells in rat, man and mouse. Data on the functions of the two rat CD4+ T-cell subsets isolated on the basis of different levels of expression of exon B (and/or C) are largely concordant with those obtained from the two subsets of human CD4+ T cells defined by their levels of expression of exon A. However, results presented in this paper on the CD45 phenotype of rat T cells that produce interferon-gamma (IFN-gamma) are not compatible with the human data, if it is assumed that there are only two functional subsets of CD4+ T cells. The data could, in principle, be reconciled if the expression of exons A and B defined three rather than two subsets, and this possibility has now been examined in man where monoclonal antibodies against both A and B exon products are available. The results show the presence of a third CD4+ T-cell subset and that this extra subset is contained within the population originally shown to provide memory T-cell function.

Animals↗
PubMed1989

The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype.

CD4+ T cells in the rat can be divided into two nonoverlapping subsets by their reactivity with the mAb MRC OX-22, which binds some of the high molecular weight forms of the CD45 antigen. The lineage relationship between subsets of CD4+ T cells expression different forms of CD45 has been a controversial issue for some time. Experiments described in this paper address this question using in vivo assays of T cell reactivity. Analysis of primary antibody responses in vivo show that it is MRC OX-22+ CD4+ T cells that are active in these assays, whereas antigen-primed T cells that provide helper activity for secondary antibody responses in vivo have the MRC OX-22- CD4+ phenotype. It is demonstrated that these memory T cells derive from MRC OX-22+ CD4+ T cell precursors and not from a putative separate lineage. It is concluded that with respect to the provision of help for B cells, MRC OX-22+ CD4+ T cells are precursors of memory cells with the phenotype MRC OX-22- CD4+.

Animals↗
PubMed1985

Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione.

Glutathione monoethyl ester (L-gamma-glutamyl-L-cysteinylglycyl ethyl ester), in contrast to glutathione itself, is effectively transported into many types of cells. The ester is converted intracellularly into glutathione. Intraperitoneal injection of 35S-labeled ester into mice was followed by rapid appearance of isotope in the glutathione of liver, kidney, spleen, pancreas, and heart; the glutathione levels of these tissues also increased. Oral administration of the ester to mice also increased cellular glutathione levels. Relatively little extracellular deesterification was found. Transport of glutathione ester into human erythrocytes and intracellular conversion to glutathione was observed. The findings suggest that the glutathione ester will be useful as a radioprotecting agent and in the prevention and treatment of toxicity due to certain foreign compounds and oxygen. The ester may be useful in experimental work on glutathione transport, metabolism, and function, and in related studies on oxygen toxicity, radiation, mutagenesis, and ageing. Methods for the preparation of glutathione monoethyl ester and several related compounds are given.

Administration, Oral↗
PubMedDate not supplied

The role of IL-10 in inflammatory bowel disease: "of mice and men".

Inflammatory bowel disease (IBD) is a generic term typically used to describe a group of idiopathic inflammatory intestinal conditions in humans that are generally divided into Crohn's disease and ulcerative colitis. Although the etiology of these diseases remains unknown, a number of rodent models of IBD have recently been identified, all sharing the concept that the development of chronic intestinal inflammation occurs as a consequence of alterations in the immune system that lead to a failure of normal immunoregulation in the intestine. On the basis of these models, it has been hypothesized that the development of IBD in humans may be related to a dysregulated immune response to normal flora in the gut. Immunodeficient scid mice injected with CD4+ CD45RB(high) T cells and mice deficient in interleukin (IL)-10 (IL-10-/-) are among the rodent models of IBD. In both models, there is inflammation and evidence of a Th1-like response in the large intestine, characterized by CD4+ T-cell and macrophage infiltrates, and elevated levels of interferon-gamma. Because IL-10 is an immunomodulatory cytokine that is capable of controlling Th1-like responses, the role of IL-10 was investigated in these models. IL-10 was shown to be important in regulating the development of intestinal inflammation in both models. These results provided key data that supported initiation of clinical trials evaluating the efficacy of IL-10 in patients with IBD.

Animals↗